Skip to main content
BML, INC. logo

BML, INC. — Investor Relations & Filings

Ticker · 4694 ISIN · JP3799700004 LEI · 5493003Y6Y1P8HBEL806 T Human health and social work activities
Open in API
Filings indexed 80 across all filing types
Latest filing 2024-06-27 Regulatory Filings
Country US United States of America
Listing T 4694

About BML, INC.

https://www.bml.co.jp/eng/

BML, Inc. is a provider of comprehensive laboratory testing services and medical information systems. The company's core business is contract clinical testing for medical institutions, offering a wide range of laboratory analyses. These services span from routine biochemical and hematological tests to specialized areas such as microbiological, genome-related, and tumor marker testing. In addition to its laboratory operations, BML develops and provides medical informatics solutions, including software for clinical testing. The company operates an extensive network of laboratories to process samples and report results to customers in the medical field.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings
2024-06-27 Japanese
内部統制報告書－第69期(2023/04/01－2024/03/31)
Governance Information Classification · 1% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法). The content discusses the framework, scope, and results of the assessment of internal controls over financial reporting (財務報告に係る内部統制の評価) as of the fiscal year-end (2024年３月31日). This directly corresponds to the requirements for an internal control report, which is typically filed alongside the Annual Report (10-K) in Japan, but based on the provided definitions, it is most closely related to an Audit Report/Information (AR) or a specific regulatory filing. Given the specific nature of an 'Internal Control Report' which involves an assessment of controls, it aligns best with the scope of 'Audit Report / Information' (AR) which covers applied accounting principles and results of internal/regulatory stress tests, as it is a formal assessment document. However, in the context of US SEC filings where these codes originate, an Internal Control Report is a mandatory component of the 10-K. Since the definitions provided do not have a specific code for 'Internal Control Report', and it is a formal, comprehensive report on internal processes rather than a brief announcement (like RPA) or a general earnings release (ER), it is best classified under the most relevant comprehensive report category or the fallback. Given the options, 'AR' (Audit Report / Information) is the closest fit for a formal assessment document concerning financial integrity, although 'RNS' (Regulatory Filings) is also plausible if it's considered a specific Japanese regulatory filing not covered elsewhere. Since it is a detailed report on internal controls, I will classify it as AR, as it is an assessment report.
2024-06-27 Japanese
有価証券報告書－第69期(2023/04/01－2024/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of the US 10-K. It is filed under the Financial Instruments and Exchange Act, covers a full fiscal year (2023-04-01 to 2024-03-31), and contains comprehensive financial data and corporate disclosures. Therefore, it is classified as an Annual Report (10-K). FY 2024
2024-06-27 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (582 characters) and contains a table structure typical of a cover page for a regulatory filing in Japan. Key Japanese terms include: '【提出書類】確認書' (Filing Document: Confirmation Document), '【根拠条文】金融商品取引法' (Basis Article: Financial Instruments and Exchange Act), and '【提出先】関東財務局長' (Filing Destination: Director of the Kanto Local Finance Bureau). Section 1 explicitly states that the CEO confirms the appropriateness of the '第69期第３四半期...の四半期報告書' (3rd Quarter Report for the 69th Fiscal Period). This document is not the full Quarterly Report (IR) itself, but rather a formal confirmation/attestation regarding that report. Since there is no specific code for a 'Confirmation Document' related to a quarterly report, and given its nature as a formal regulatory submission confirming another document's accuracy, it falls best under the general 'Regulatory Filings' (RNS) category, as it is a required regulatory submission that doesn't fit the comprehensive report codes (like IR or 10-K). It is not an announcement of a report publication (RPA) but the submission of a required confirmation document.
2024-02-14 Japanese
四半期報告書－第69期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed by BML, Inc. in Japan. It contains detailed financial statements, including the balance sheet and income statement for the third quarter of the 69th fiscal year (April 1, 2023, to December 31, 2023). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (581 characters) and contains a table structure typical of a cover page for a regulatory filing in Japan. Key Japanese terms are present: '【提出書類】確認書' (Filing Document: Confirmation Document), '【根拠条文】金融商品取引法' (Legal Basis: Financial Instruments and Exchange Act), and '四半期報告書' (Quarterly Report). The core content confirms that the President has verified the appropriateness of the 'Quarterly Report' for the second quarter (July 1 to September 30, 2023). Since this document is a 'Confirmation Document' regarding the Quarterly Report, and not the comprehensive Quarterly Report itself, it fits best under the general 'Regulatory Filings' category (RNS) or potentially a specific confirmation/attestation filing if one existed. Given the provided definitions, and the fact that it is a short regulatory confirmation rather than a full financial report (IR) or an announcement of a report (RPA), RNS is the most appropriate fallback for a specific regulatory attestation not explicitly listed. However, since it directly relates to the content and verification of an 'Interim/Quarterly Report' (IR), and is a formal regulatory submission, RNS is the safest general classification for non-standard regulatory confirmations.
2023-11-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.